Drug
P2Y12 Inhibitor clinical trials
- studies test it
- 7
- open now
- 3
- in phase 3
- 1
- first study started
- 2012
Keep track of what changes. Save the P2Y12 Inhibitor studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2017 (3)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 3
- 1
- Phase 4
- 2
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 5
ECRI bv (1) · Aggredyne, Inc. (1) · Ochsner Health System (1) · Jilin University (1) · UMC Utrecht (1) · Humanitas Hospital, Italy (1) · Samsung Medical Center (1)
Often tested with
Tested in the same studies.
Aspirin (4) · Ceftriaxone (1) · Piperacillin, Tazobactam Drug Combination (1) · Ceftaroline (1) · Amoxicillin (1) · Clavulanic Acid (1) · Lopinavir-ritonavir drug combination (1) · Hydroxychloroquine (1)
Studies
Open first, then newest update. How each study uses P2Y12 Inhibitor is read from its arms, and is right about nine times in ten.
Testing it · 7
- Aspirin 50mg vs 100mg Combined With P2Y12 Inhibitor After PCIRecruitingNot applicableJilin UniversityNCT07846462Written as P2Y12 inhibitor
- Colonoscopy and Antiplatelet Therapy TrialNot yet recruitingPhase 4Ochsner Health SystemNCT06613191Written as P2Y12 inhibitor (clopidogrel, ticagrelor, prasugrel)
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired PneumoniaRecruitingPhase 3UMC UtrechtNCT02735707Written as P2Y12 inhibitor
- Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT RegimenCompletedNot applicableECRI bvNCT03023020Written as P2Y12 inhibitor
- Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPTStatus unknownPhase 4Humanitas Hospital, ItalyNCT03112707Written as P2Y12 inhibitor
- Study of AggreGuide A-100 (ADP) AssayCompletedNot applicableAggredyne, Inc.NCT03111420Written as P2Y12 inhibitor
- Safety of 6-month Duration of Dual Antiplatelet Therapy After Acute Coronary Syndromes (SMART-DATE)Status unknownNot applicableSamsung Medical CenterNCT01701453Written as P2Y12 inhibitor (clopidogrel, ticagrelor, prasugrel)